KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Depreciation and Depletion (2021 - 2025)

Historic Depreciation and Depletion for LifeMD (LFMD) over the last 9 years, with Q3 2025 value amounting to $262747.0.

  • LifeMD's Depreciation and Depletion rose 7362.29% to $262747.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $775847.0, marking a year-over-year increase of 10451.26%. This contributed to the annual value of $487976.0 for FY2024, which is 13926.02% up from last year.
  • According to the latest figures from Q3 2025, LifeMD's Depreciation and Depletion is $262747.0, which was up 7362.29% from $184256.0 recorded in Q2 2025.
  • In the past 5 years, LifeMD's Depreciation and Depletion ranged from a high of $262747.0 in Q3 2025 and a low of $10695.0 during Q4 2021
  • Its 5-year average for Depreciation and Depletion is $92129.8, with a median of $53759.0 in 2023.
  • As far as peak fluctuations go, LifeMD's Depreciation and Depletion surged by 31960.73% in 2022, and later soared by 1391.88% in 2023.
  • LifeMD's Depreciation and Depletion (Quarter) stood at $10695.0 in 2021, then skyrocketed by 319.61% to $44877.0 in 2022, then increased by 28.5% to $57666.0 in 2023, then soared by 188.35% to $166278.0 in 2024, then soared by 58.02% to $262747.0 in 2025.
  • Its Depreciation and Depletion was $262747.0 in Q3 2025, compared to $184256.0 in Q2 2025 and $162566.0 in Q1 2025.